| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA628290 | P | Calculated membrane partition coefficient (Kmemb) | 75 | ALA1149124 | small-molecule physicochemical format | Scientific Literature | ||
| 2. | ALA651228 | F | The compound was tested for minimal inhibitory concentration against Bacillus subtilis | Bacillus subtilis | 4 | ALA1134904 | organism-based format | Scientific Literature | |
| 3. | ALA679095 | F | The compound was tested for minimal inhibitory concentration against Enterobacter sp. | Enterobacter | 4 | ALA1134904 | organism-based format | Scientific Literature | |
| 4. | ALA676759 | F | Minimum inhibition concentration against Enterococcus faecalis | Enterococcus faecalis | 7 | ALA1134864 | organism-based format | Scientific Literature | |
| 5. | ALA676760 | F | Minimum inhibitory activity against tetracycline-susceptible Enterococcus faecalis strain ATCC 9790 | Enterococcus faecalis | 4 | ALA1127651 | organism-based format | Scientific Literature | |
| 6. | ALA878283 | F | Minimum inhibitory activity against tetracycline-susceptible Enterococcus faecalis strain ATCC 9790 (Tet L on plasmid MV158) | Enterococcus faecalis | 4 | ALA1127651 | organism-based format | Scientific Literature | |
| 7. | ALA674558 | F | Growth inhibitory activity against tetracycline-resistant ML308-225 bacterial strain of Escherichia coli | Escherichia coli | 3 | ALA1127651 | organism-based format | Scientific Literature | |
| 8. | ALA859396 | F | Inhibitory activity against tetracycline uptake in everted membrane vesicles derived from Tc-resistant Escherichia coli bearing class B tetracycline resistance efflux protein (Tet) | Escherichia coli | 1 | ALA1127651 | organism-based format | Scientific Literature | |
| 9. | ALA873604 | F | Inhibitory activity against tetracycline uptake in everted membrane vesicles derived from Tc-resistant Escherichia coli bearing class B tetracycline resistance efflux protein (Tet) | Escherichia coli | 47 | ALA1127651 | organism-based format | Scientific Literature | |
| 10. | ALA676263 | F | Minimum inhibitory activity against tetracycline-susceptible Escherichia coli strain D31m4 | Escherichia coli | 4 | ALA1127651 | organism-based format | Scientific Literature | |
| 11. | ALA878400 | F | Minimum inhibitory activity against tetracycline-susceptible Escherichia coli strain D31m4 (Tet B on plasmid pHCMI) | Escherichia coli | 4 | ALA1127651 | organism-based format | Scientific Literature | |
| 12. | ALA674601 | F | Minimum inhibitory activity against tetracycline-susceptible Escherichia coli strain ML308-225 (Tet A on plasmid pIP15) | Escherichia coli | 4 | ALA1127651 | organism-based format | Scientific Literature | |
| 13. | ALA674605 | F | Minimum inhibitory activity against tetracycline-susceptible Escherichia coli strain ML308-225 (Tet B on plasmid R222) | Escherichia coli | 4 | ALA1127651 | organism-based format | Scientific Literature | |
| 14. | ALA673722 | F | The compound was tested for minimal inhibitory concentration against Escherichia coli | Escherichia coli | 4 | ALA1134904 | organism-based format | Scientific Literature | |
| 15. | ALA689959 | F | The compound was tested for minimal inhibitory concentration against Haemophilus ducreyi | [Haemophilus] ducreyi | 4 | ALA1134904 | organism-based format | Scientific Literature | |
| 16. | ALA693797 | F | Compound was evaluated for the inhibition of cell proliferation of human hepatocellular carcinoma, HepG2 (ATCC HB8065). | Homo sapiens | 6 | ALA1152061 | cell-based format | Scientific Literature | |
| 17. | ALA693808 | F | Compound was evaluated for the cytotoxicity against human hepatocellular carcinoma, HepG2 (ATCC HB8065) | Homo sapiens | 7 | ALA1152061 | cell-based format | Scientific Literature | |
| 18. | ALA696873 | F | Compound was evaluated for the cytotoxicity against human cervix epithelioid carcinoma, HeLa (ATCC CCL2). | Homo sapiens | 6 | ALA1152061 | cell-based format | Scientific Literature | |
| 19. | ALA698120 | F | Compound was evaluated for the inhibition of cell proliferation of human cervix epithelioid carcinoma, HeLa (ATCC CCL2). | Homo sapiens | 4 | ALA1152061 | cell-based format | Scientific Literature | |
| 20. | ALA702885 | B | Binding constant against human serum albumin (HSA) | 95 | ALA1134302 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!